Therapeutic potential of Takeda‐ G ‐protein‐receptor‐5 ( TGR5 ) agonists. Hope or hype?
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The gastrointestinal tract regulates glucose and energy metabolism, and there is increasing recognition that bile acids function as key signalling molecules in these processes. For example, bile acid changes that occur after bariatric surgery have been implicated in the effects on satiety, lipid and cholesterol regulation, glucose and energy metabolism, and the gut microbiome. In recent years, T akeda‐ G ‐protein‐receptor‐5 ( TGR5 ), a bile acid receptor found in widely dispersed tissues, has been the target of significant drug discovery efforts in the hope of identifying effective treatments for metabolic diseases including type 2 diabetes, obesity, atherosclerosis, fatty liver disease and cancer. Although the benefits of targeting the TGR5 receptor are potentially great, drug development work to date has identified risks that include histopathological changes, tumorigenesis, gender differences, and questions about the translation of animal data to humans. The present article reviews the noteworthy challenges that must be addressed along the path of development of a safe and effective TGR5 agonist therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · cited 1×
“In enteroendocrine cells, it stimulates the release of both glucagon-like peptide-1 (GLP-1), influencing glucose homeostasis [14], and peptide tyrosine tyrosine (PYY) which regulates food intake [15].”
BackgroundA G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 3×
“Further complicating this picture is an evolving recognition that there may be significant interplay between gender and the gut microbiome [36], which may be pertinent since secondary bile acids generated by gut bacteria are potent endogenous ligands for the TGR5 receptor [1].”
BackgroundBile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696 · cited 1×
“The Takeda G-protein coupled receptor-5 (TGR5) membrane-bound bile acid receptor [also known as Gpbar1, membrane-type bile acid receptor (M-BAR), GPR131, BG37 and Axor109] [1,2] has been the focus of significant investigation, and numerous review articles have highlighted the potential value of TGR5 agonists in the tr…”
BackgroundBacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells
Chimerel, C., Emery, E., Summers, D. K., Keyser, U., Gribble, F. M., & Reimann, F. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.032 · Cited by 548 · cited 1×
“In addition, indole, a bacterial metabolite of tryptophan, has been shown to stimulate GLP-1 release at low concentrations, but inhibit its secretion at high concentrations [42].”
BackgroundThe bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.004 · Cited by 454
Magee, E. A., Richardson, C. J., Hughes, R., & Cummings, J. H. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.6.1488 · Cited by 359 · cited 1×
“Western diets contain much higher levels of sulphates than more ‘traditional’ diets as a result of both the use of sulphate preservatives in processed food [40] and higher consumption of animal proteins with sulphur-containing amino acids [41].”
BackgroundDegirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., & Moschetta, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.032 · Cited by 356
The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
Keitel, V., Görg, B., Bidmon, H. J., Zemtsova, I., Spomer, L., Zilles, K., & Häussinger, D. (2010) · Glia · doi:10.1002/glia.21049 · Cited by 274 · cited 1×
“This receptor is also located in neurons of the enteric nervous system, where they influence gut motility [17], and in neurons and astrocytes in the central nervous system, where its function is unknown, other than that TGR5 mRNA levels are reduced in brain tissue from patients with hepatic encephalopathy [18].”
BackgroundKumar, D. P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.104 · Cited by 206 · cited 1×
“TGR5 activation in pancreatic islet β cells can increase insulin secretion [19], while agonism has been shown to protect the kidney in models of diabetes and obesity [20], and it has even been proposed as a therapy for heart failure [21].”
Background
Cited by
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Bile acids in glucose metabolism in health and disease
Shapiro, H., Kolodziejczyk, A. A., Halstuch, D., & Elinav, E. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171965 · Cited by 464
Bile acids as modulators of gut microbiota composition and function
Larabi, A. B., Masson, H. L. P., & Bäumler, A. J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2172671 · Cited by 401
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 400
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
Metadata
- Authors
- Hodge, R. J., & Nunez, D. J.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2016-03-17
- Volume
- 18
- Issue
- 5
- Pages
- 439-443
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2339269771
- Cited by
- 63
- References
- 11
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic potential of Takeda‐ G ‐protein‐receptor‐5 ( TGR5 ) agonists. Hope or hype? https://app.cochat.ai/papers/10.1111/dom.12636
- The paper
- Hodge, R. J., & Nunez, D. J. (2016). Therapeutic potential of Takeda‐ G ‐protein‐receptor‐5 ( TGR5 ) agonists. Hope or hype? Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.